Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile

BACKGROUND: Understanding the changes that occur in the transitional stage between absent and overt amyloid-β (Aβ) pathology within the Alzheimer’s continuum is crucial to develop therapeutic and preventive strategies. The objective of this study is to test whether cognitively unimpaired individuals...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Alzheimers Res Ther
Auteurs principaux: Milà-Alomà, Marta, Shekari, Mahnaz, Salvadó, Gemma, Gispert, Juan Domingo, Arenaza-Urquijo, Eider M., Operto, Grégory, Falcon, Carles, Vilor-Tejedor, Natalia, Grau-Rivera, Oriol, Sala-Vila, Aleix, Sánchez-Benavides, Gonzalo, González-de-Echávarri, José Maria, Minguillon, Carolina, Fauria, Karine, Niñerola-Baizán, Aida, Perissinotti, Andrés, Simon, Maryline, Kollmorgen, Gwendlyn, Zetterberg, Henrik, Blennow, Kaj, Suárez-Calvet, Marc, Molinuevo, José Luis
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314554/
https://ncbi.nlm.nih.gov/pubmed/34315519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-021-00863-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires